{
  "CitationSubset": [
    "IM"
  ],
  "KeywordList": [
    [
      "Blood glucose",
      "COVID-19",
      "Diabetes",
      "Pharmacotherapy",
      "Steroids"
    ]
  ],
  "GeneralNote": [],
  "OtherAbstract": [],
  "SpaceFlightMission": [],
  "OtherID": [],
  "InvestigatorList": [],
  "PMID": "34186344",
  "DateCompleted": {
    "Year": "2021",
    "Month": "08",
    "Day": "23"
  },
  "DateRevised": {
    "Year": "2021",
    "Month": "08",
    "Day": "23"
  },
  "Article": {
    "ArticleDate": [
      {
        "Year": "2021",
        "Month": "06",
        "Day": "10"
      }
    ],
    "Language": [
      "eng"
    ],
    "ELocationID": [
      "10.1016/j.dsx.2021.06.004",
      "S1871-4021(21)00185-5"
    ],
    "Journal": {
      "ISSN": "1878-0334",
      "JournalIssue": {
        "Volume": "15",
        "Issue": "4",
        "PubDate": {
          "Year": "2021",
          "Season": "Jul-Aug"
        }
      },
      "Title": "Diabetes & metabolic syndrome",
      "ISOAbbreviation": "Diabetes Metab Syndr"
    },
    "ArticleTitle": "Steroid use during COVID-19 infection and hyperglycemia - What a physician should know.",
    "Pagination": {
      "StartPage": "102167",
      "MedlinePgn": "102167"
    },
    "Abstract": {
      "AbstractText": [
        "The COVID-19 pandemic continues to challenge us. Despite several strides in management, steroids remain the mainstay for treating moderate to severe disease and with it arises challenges such as hyperglycemia. The review aims to enhance awareness amongst physicians on steroid use and hyperglycemia.",
        "An advisory document describing various strategies for hyperglycemia management was prepared in the public interest by DiabetesIndia.",
        "The review provides awareness on steroids and hyperglycemia, adverse outcomes of elevated blood glucose levels and, advice at the time of discharge.",
        "The article emphasizes enhancing awareness on effective management of hyperglycemia during COVID-19."
      ],
      "CopyrightInformation": "Copyright \u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved."
    },
    "AuthorList": [
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Diacon Hospital, Bangalore, India. Electronic address: draravind@hotmail.com."
          }
        ],
        "LastName": "Sosale",
        "ForeName": "Aravind",
        "Initials": "A"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Diacon Hospital, Bangalore, India. Electronic address: bhavanasosale@gmail.com."
          }
        ],
        "LastName": "Sosale",
        "ForeName": "Bhavana",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Jothydev's Diabetes Research Centers, Kerala, India. Electronic address: jothydev@gmail.com."
          }
        ],
        "LastName": "Kesavadev",
        "ForeName": "Jothydev",
        "Initials": "J"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Lina Diabetes Center, Mumbai, India. Electronic address: dr_manoj@hotmail.com."
          }
        ],
        "LastName": "Chawla",
        "ForeName": "Manoj",
        "Initials": "M"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Center For Diabetes & Endocrine Care (CDE), Bangalore, India. Electronic address: drsanjaycreddy@yahoo.com."
          }
        ],
        "LastName": "Reddy",
        "ForeName": "Sanjay",
        "Initials": "S"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Diabetologist, Diacare, Diabetes Care & Hormone Clinic, Ahmedabad, India. Electronic address: banshisaboo98@gmail.com."
          }
        ],
        "LastName": "Saboo",
        "ForeName": "Banshi",
        "Initials": "B"
      },
      {
        "Identifier": [],
        "AffiliationInfo": [
          {
            "Identifier": [],
            "Affiliation": "Fortis-C-DOC Centre of Excellence for Diabetes, Metabolic Diseases and Endocrinology, Chairman, National Diabetes, Obesity and Cholesterol Foundation (N-DOC), President, Diabetes Foundation India (DFI), India. Electronic address: anoopmisra@gmail.com."
          }
        ],
        "LastName": "Misra",
        "ForeName": "Anoop",
        "Initials": "A"
      }
    ],
    "PublicationTypeList": [
      "Journal Article",
      "Review"
    ]
  },
  "MedlineJournalInfo": {
    "Country": "Netherlands",
    "MedlineTA": "Diabetes Metab Syndr",
    "NlmUniqueID": "101462250",
    "ISSNLinking": "1871-4021"
  },
  "ChemicalList": [
    {
      "RegistryNumber": "0",
      "NameOfSubstance": "Steroids"
    }
  ],
  "MeshHeadingList": [
    {
      "QualifierName": [
        "complications",
        "transmission",
        "virology"
      ],
      "DescriptorName": "COVID-19"
    },
    {
      "QualifierName": [],
      "DescriptorName": "Humans"
    },
    {
      "QualifierName": [
        "drug therapy",
        "virology"
      ],
      "DescriptorName": "Hyperglycemia"
    },
    {
      "QualifierName": [
        "isolation & purification"
      ],
      "DescriptorName": "SARS-CoV-2"
    },
    {
      "QualifierName": [
        "therapeutic use"
      ],
      "DescriptorName": "Steroids"
    }
  ]
}